Royalty Pharma Reports Results for Quarter Ended June 30, 2026

What Happened

• On August 5, 2026, Royalty Pharma plc (RPRX) filed a Form 8-K (Item 2.02) furnishing a press release that announces the company’s financial results for the quarter ended June 30, 2026.
• The press release is included as Exhibit 99.1 to the Form 8-K and the filing also includes the Inline XBRL cover page (Exhibit 104).

Key Details

• Filing date: August 5, 2026 (Form 8-K).
• Reporting period: quarter ended June 30, 2026.
• Exhibit furnished: Press release announcing quarterly financial results (Exhibit 99.1).
• Interactive data: Cover Page Interactive Data File embedded as Inline XBRL (Exhibit 104).

Why It Matters

• This 8-K signals that Royalty Pharma has released its latest quarterly financial results; investors should read the furnished press release for revenue, earnings, guidance, and other operating details.
• Because the press release was furnished as an exhibit, investors should review the exhibit itself (and other SEC filings) for the specific numbers and management commentary necessary to assess near-term financial performance.